Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Commerzbank Downgrades Swiss Re to Hold

Commerzbank downgrades Swiss Re (OTC:SSREY) from Buy to Hold.

byBenzinga Newsdesk

July 19, 2021

1 minute read

Commerzbank downgrades Swiss Re (OTC:SSREY) from Buy to Hold.

Citigroup Downgrades Dollar Gen to Neutral, Announces $258 Price Target

By Benzinga Newsdesk

July 14, 6:25 AM

Citigroup analyst Paul Lejuez downgrades Dollar Gen (NYSE:DG) from Buy to Neutral and announces $258 price target.

Analyst Ratings

4 Analysts Have This to Say About Radius Health

By Benzinga Insights

June 24, 8:41 AM

Analysts have provided the following ratings for Radius Health (NASDAQ:RDUS) within the last quarter:

RDUS

OFS Capital Q4 Adj EPS $0.35, Inline, Sales $14.00M Beat $13.79M Estimate

By Benzinga Newsdesk

March 3, 9:02 AM

OFS Capital (NASDAQ:OFS) reported quarterly earnings of $0.35 per share which met the analyst consensus estimate. The company reported quarterly sales of $14.00 million which beat the analyst consensus estimate of $13.79

OFS

RBC Capital Maintains Outperform on AAR, Raises Price Target to $56

By Benzinga Newsdesk

March 23, 9:32 AM

RBC Capital analyst Ken Herbert maintains AAR (NYSE:AIR) with a Outperform and raises the price target from $50 to $56.

AIR

Commerzbank Downgrades Swiss Re to Hold

Related Posts

Citigroup Downgrades Dollar Gen to Neutral, Announces $258 Price Target

4 Analysts Have This to Say About Radius Health

OFS Capital Q4 Adj EPS $0.35, Inline, Sales $14.00M Beat $13.79M Estimate

RBC Capital Maintains Outperform on AAR, Raises Price Target to $56